Kairos Pharma Statistics

Total Valuation

Kairos Pharma has a market cap or net worth of $18.08 million. The enterprise value is $18.10 million.

Market Cap	18.08M
Enterprise Value	18.10M

Important Dates

The next estimated earnings date is Saturday, November 23, 2024, before market open.

Earnings Date	Nov 23, 2024
Ex-Dividend Date	n/a

Share Statistics

Kairos Pharma has 12.84 million shares outstanding. The number of shares has increased by 1.77% in one year.

Current Share Class	n/a
Shares Outstanding	12.84M
Shares Change (YoY)	+1.77%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	59.24%
Owned by Institutions (%)	n/a
Float	4.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	693.46
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	723.94

Financial Position

The company has a current ratio of 0.01

Current Ratio	0.01
Quick Ratio	0.01
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	31.32
Interest Coverage	-16.29

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-117.65%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$668,667
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	29.68
Average Volume (20 Days)	41,665

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-1.89M
Pretax Income	-812,000
Net Income	-2.01M
EBITDA	-1.73M
EBIT	-1.89M
Earnings Per Share (EPS)	-$0.19

Full Income Statement

Balance Sheet

The company has $21,000 in cash and $783,000 in debt, giving a net cash position of -$762,000 or -$0.06 per share.

Cash & Cash Equivalents	21,000
Total Debt	783,000
Net Cash	-762,000
Net Cash Per Share	-$0.06
Equity (Book Value)	-2.65M
Book Value Per Share	-0.25
Working Capital	-2.97M

Full Balance Sheet

Cash Flow

Operating Cash Flow	25,000
Capital Expenditures	n/a
Free Cash Flow	25,000
FCF Per Share	$0.00

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Kairos Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.77%
Shareholder Yield	-1.77%
Earnings Yield	-11.57%
FCF Yield	0.14%

Analyst Forecast

The average price target for Kairos Pharma is $9.00, which is 539.34% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.00
Price Target Difference	539.34%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2